RLMD
Relmada Therapeutics Inc
3.80$
+1.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +41.1% | -9.8% | -19.4% | +4.0% | -1.3% | +8.6% | -76.4% | +43.2% | +100.0% | +0.2% | +3.8% | – | |
| – | -1.3% | -19.8% | -16.4% | +46.5% | -31.9% | -22.4% | +18.1% | -15.0% | +94.9% | -7.2% | -41.8% | – | |
| – | +18.2% | -14.3% | -18.1% | +22.3% | -17.1% | -4.5% | -43.9% | +1.0% | +96.9% | -4.3% | -22.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1,411.7% | – | +22.0% | -67.4% | -4,296.6% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.